Providence Capital Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$4.11M |
| 2 |
Corning
GLW
|
+$4.02M |
| 3 |
Baxter International
BAX
|
+$3.78M |
| 4 |
Boston Scientific
BSX
|
+$3.65M |
| 5 |
CSX Corp
CSX
|
+$3.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$4.44M |
| 2 |
Microsoft
MSFT
|
+$3.74M |
| 3 |
Johnson Controls International
JCI
|
+$3.69M |
| 4 |
United Parcel Service
UPS
|
+$3.39M |
| 5 |
Lowe's Companies
LOW
|
+$3.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 12.68% |
| 4 | Communication Services | 10.01% |
| 5 | Consumer Staples | 8.81% |
Similar funds
Providence Capital Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Providence Capital Advisors held 358 positions worth $321M, up 3.7% from $309M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Providence Capital Advisors deployed $16.1M of net new capital in Q3 2021, opening 36 new positions and adding to 93 existing holdings. Its largest new stake was Boston Scientific: 82,600 shares worth $3.58M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $4.44M trimmed.
- Providence Capital Advisors's largest Q3 2021 buy was Boston Scientific: 82,600 shares worth $3.58M.
- Providence Capital Advisors added most to Starbucks in Q3 2021, an estimated $4.11M increase.
- Providence Capital Advisors's biggest Q3 2021 reduction was Gilead Sciences, cutting an estimated $4.44M.
- Providence Capital Advisors fully exited Johnson Controls International in Q3 2021, selling an estimated $3.69M.
- Providence Capital Advisors's ten largest holdings make up 26% of its $321M portfolio in Q3 2021.
- Providence Capital Advisors opened 36 new positions and closed 39 in Q3 2021.
- Providence Capital Advisors's portfolio value rose 3.7% quarter-over-quarter to $321M.
Based on Providence Capital Advisors's 13F filing for Q3 2021, filed 9 Nov 2021.